A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model

Hedwig M. Blommestein; Silvia G. R. Verelst; Saskia de Groot; Peter C. Huijgens; Pieter Sonneveld; Carin A. Uyl-de Groot

doi:10.1111/ejh.12571

A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model

Hedwig M. Blommestein, Silvia G. R. Verelst, Saskia de Groot, Peter C. Huijgens, Pieter Sonneveld, Carin A. Uyl-de Groot

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	198-208
Journal	European Journal of Haematology
Volume	96
Issue number	2
DOIs	https://doi.org/10.1111/ejh.12571
Publication status	Published - Feb 2016

Access to Document

10.1111/ejh.12571

Cite this

@article{efea8feb37754d189555b6667a81b3b0,

title = "A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model",

keywords = "multiple myeloma, cost-effectiveness analysis, real-world data, registries, thalidomide, bortezomib, lenalidomide",

author = "Blommestein, {Hedwig M.} and Verelst, {Silvia G. R.} and {de Groot}, Saskia and Huijgens, {Peter C.} and Pieter Sonneveld and {Uyl-de Groot}, {Carin A.}",

year = "2016",

month = feb,

doi = "10.1111/ejh.12571",

language = "English",

volume = "96",

pages = "198--208",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "Wiley-Blackwell",

number = "2",

}

A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model. / Blommestein, Hedwig M.; Verelst, Silvia G. R.; de Groot, Saskia; Huijgens, Peter C.; Sonneveld, Pieter; Uyl-de Groot, Carin A.

In: European Journal of Haematology, Vol. 96, No. 2, 02.2016, p. 198-208.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model

AU - Blommestein, Hedwig M.

AU - Verelst, Silvia G. R.

AU - de Groot, Saskia

AU - Huijgens, Peter C.

AU - Sonneveld, Pieter

AU - Uyl-de Groot, Carin A.

PY - 2016/2

Y1 - 2016/2

KW - multiple myeloma

KW - cost-effectiveness analysis

KW - real-world data

KW - registries

KW - thalidomide

KW - bortezomib

KW - lenalidomide

U2 - 10.1111/ejh.12571

DO - 10.1111/ejh.12571

M3 - Article

C2 - 25892333

VL - 96

SP - 198

EP - 208

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 2

ER -